On Wednesday, April 3, 2019, Commissioner Kim Jin-yong visited the DM Bio site in Songdo International City. Dong-A Soshi Holdings has established a biopharmaceutical manufacturing facility (DM Bio) in Songdo International City in partnership with Japan's Meiji Seika Pharma. DM Bio is engaged in the production and supply of antibody medicines and recombinant proteins jointly developed by two companies, CDMO (drug consignment development and consignment production) business, and has more than 200 high-level human resources.